J Med Microbiol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Enoch, D. A.
Right arrow Articles by Brown, N. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Enoch, D. A.
Right arrow Articles by Brown, N. M.
Agricola
Right arrow Articles by Enoch, D. A.
Right arrow Articles by Brown, N. M.
J Med Microbiol 55 (2006), 809-818; DOI: 10.1099/jmm.0.46548-0
© 2006 Society for General Microbiology
ISSN 1473-5644

Review

Invasive fungal infections: a review of epidemiology and management options

D. A. Enoch, H. A. Ludlam and N. M. Brown

Clinical Microbiology and Public Health Laboratory, Health Protection Agency, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QW, UK

Correspondence
D. A. Enoch
david.enoch{at}addenbrookes.nhs.uk


Fungi are increasingly recognised as major pathogens in critically ill patients. Candida spp. and Cryptococcus spp. are the yeasts most frequently isolated in clinical practice. The most frequent filamentous fungi (moulds) isolated are Aspergillus spp., but Fusarium spp., Scedosporium spp., Penicillium spp., and Zygomycetes are increasingly seen. Several reasons have been proposed for the increase in invasive fungal infections, including the use of antineoplastic and immunosuppressive agents, broad-spectrum antibiotics, and prosthetic devices and grafts, and more aggressive surgery. Patients with burns, neutropenia, HIV infection and pancreatitis are also predisposed to fungal infection. The epidemiology and clinical features of fungal infections are reviewed, together with antifungal agents currently or soon to be available.




This article has been cited by other articles:


Home page
 J. Clin. Microbiol.Home page
X. Zhou, F. Kong, T. C. Sorrell, H. Wang, Y. Duan, and S. C. A. Chen
Practical Method for Detection and Identification of Candida, Aspergillus, and Scedosporium spp. by Use of Rolling-Circle Amplification
J. Clin. Microbiol., July 1, 2008; 46(7): 2423 - 2427.
[Abstract] [Full Text] [PDF]

Home page
 Clin Med ResHome page
P. M. Neal and A. Nikolai
Systemic Blastomycosis Diagnosed by Prostate Needle Biopsy
Clin. Med. Res., May 1, 2008; 6(1): 24 - 28.
[Abstract] [Full Text] [PDF]

Home page
 Microbiol. Mol. Biol. Rev.Home page
A. M. Dranginis, J. M. Rauceo, J. E. Coronado, and P. N. Lipke
A Biochemical Guide to Yeast Adhesins: Glycoproteins for Social and Antisocial Occasions
Microbiol. Mol. Biol. Rev., June 1, 2007; 71(2): 282 - 294.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
C. Eiden, H. Peyriere, M. Cociglio, S. Djezzar, S. Hansel, J.-P. Blayac, D. Hillaire-Buys, and for the Network of the French Pharmacovigilance Ce
Adverse Effects of Voriconazole: Analysis of the French Pharmacovigilance Database
Ann. Pharmacother., May 1, 2007; 41(5): 755 - 763.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2006 Society for General Microbiology.